Pacific Biosciences Of California (PACB) Free Cash Flow (2010 - 2026)
Pacific Biosciences Of California (PACB) posted quarterly Free Cash Flow of -$47.7 million for Q1 2026, down 5.04% year-over-year from -$50.3 million in Q1 2025, and down 139.51% quarter-over-quarter from -$19.9 million in Q4 2025.
Pacific Biosciences Of California (PACB) Free Cash Flow (2010 - 2026) Analysis & Trends
Pacific Biosciences Of California's Free Cash Flow history runs 17 years deep, the most recent figure standing at -$47.7 million for Q1 2026.
- In Q1 2026, Free Cash Flow fell 5.04% year-over-year to -$47.7 million; the TTM figure through Mar 2026 stood at -$116.2 million (up 34.76% YoY), while the FY2025 annual figure was -$113.9 million, up 46.33% from the prior year.
- Free Cash Flow for Q1 2026 stood at -$47.7 million, down from -$19.9 million in the prior quarter.
- The five-year high for Free Cash Flow was -$18.6 million in Q3 2025, with the low at -$98.4 million in Q1 2023.
- The 5-year median for Free Cash Flow is -$55.7 million (2024), against an average of -$54.2 million.
- The sharpest annual moves came in 2022 and 2025: Free Cash Flow plunged 273.72% in 2022, then soared 58.32% in 2025.
- Pacific Biosciences Of California's Free Cash Flow stood at -$65.5 million in 2022, then increased by 8.99% to -$59.6 million in 2023, then jumped by 45.85% to -$32.3 million in 2024, then surged by 38.23% to -$19.9 million in 2025, then slumped by 139.51% to -$47.7 million in 2026.
- Business Quant data shows PACB's Free Cash Flow at -$47.7 million in Q1 2026, -$19.9 million in Q4 2025, and -$18.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 1.99 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 1.06 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 2.09 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 1.28 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 585.00 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 184.50 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 68.00 Mn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 511.44 Mn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 279.60 Mn |
| 10 | Pacific Biosciences Of California | 381.79 Mn | 144.92 Mn | 12.64 Mn | -37.14 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -37.14 Mn |
| Jun 30, 2026 | -37.14 Mn |
| Mar 31, 2026 | -47.73 Mn |
| Mar 31, 2026 | -47.73 Mn |
| Dec 31, 2025 | -19.93 Mn |
| Dec 31, 2025 | -19.93 Mn |
| Sep 30, 2025 | -18.62 Mn |
| Sep 30, 2025 | -18.62 Mn |
| Jun 30, 2025 | -29.93 Mn |
| Jun 30, 2025 | -29.93 Mn |
| Mar 31, 2025 | -45.45 Mn |
| Mar 31, 2025 | -45.45 Mn |
| Dec 31, 2024 | -32.27 Mn |
| Dec 31, 2024 | -32.27 Mn |
| Sep 30, 2024 | -44.68 Mn |
| Sep 30, 2024 | -44.68 Mn |
| Jun 30, 2024 | -55.74 Mn |
| Jun 30, 2024 | -55.74 Mn |
| Mar 31, 2024 | -79.56 Mn |
| Mar 31, 2024 | -79.56 Mn |